Biotech Startups

Hofseth BioCare develops products derived from fish, using patented processes and R&D programs including research on asthma, COVID-19, and gastrointestinal health. The company operates in the marine bioingredients and nutraceuticals space with an emphasis on ESG.

1 investor

HOIST is an Osaka University-derived biotech venture developing anti-cancer drugs, focusing on novel modalities and mechanisms of action for cancers that lack sufficient treatments. It also provides drug discovery support using PDC/PDX approaches.

1 investor

Holistaco develops food ingredient solutions including sweetening products and antimicrobial nano-silver compounds. The company serves health-conscious consumers and food manufacturers seeking reduced-sugar and antimicrobial alternatives.

1 investor

Home Biosciences was a venture builder in Continental Europe dedicated to creating and scaling biotech companies through an asset-centric, hub-and-spoke model, working with academics and scientists on drug discovery and molecular profiling projects. It co-founded companies including One Biosciences, Sequantrix, and Apikal Therapeutics before ending day-to-day operations in January 2025 and moving to non-operating mode.

1 investor

1 investor

Amgen is a biopharmaceutical company that develops and manufactures biologic medicines using living cells to treat serious illnesses with limited existing treatment options.

1 investor

Houdini Bio develops a DNA design platform using synthetic biology and machine learning to improve genetic medicines. The platform redesigns therapeutic DNA to escape cellular silencing pathways, enabling greater durability, safety, and cost-effectiveness for genetic medicine treatments.

1 investor

HoX develops hardware, software, and chemistry capabilities to integrate biological analysis into business and health applications. The company operates an integrated system that connects biological samples, data, and analysis tools for faster biological insights.

1 investor

HTBA manufactures flavonoids, vitamin B12, and active pharmaceutical ingredients (APIs) for international customers from facilities in Spain and the United States. The company operates manufacturing plants and applications labs in Barcelona and Murcia (Spain), with a North American headquarters and lab in Cincinnati, Ohio.

1 investor

Thomson manufactures laboratory consumables including filter vials, shake flasks, well plates, and chromatography columns for pharmaceutical, biotech, environmental, toxicology, and contract manufacturing sectors.

1 investor

Knoxville-based company funded via the INCITE Fund

1 investor

Hudson River BioTech pioneers the application of Protoplast-CRISPR technology for plant breeding, developing more resilient crops for agricultural producers and consumer packaged goods companies. The company offers a proprietary BioMaas platform and develops optimized agricultural products including fruits and vegetables.

1 investor

HuidaGene develops CRISPR and RNA-guided gene editing technologies for therapeutic applications in neurology, ophthalmology, otology, myology, and hepatology. The company employs the PRECISE platform for rational engineering of nucleases to advance targeted gene therapies.

1 investor

Qoniq combines tailored AI analytics with expert guidance to help Medical Affairs and Scientific Affairs teams analyze large volumes of publications and datasets, surface patterns, and generate industry-standard, well-sourced scientific reports. It serves life sciences and pharmaceutical organizations for tasks such as post-marketing surveillance and scientific engagement.

1 investor

Human Biome develops next-generation biotherapeutics aimed at treating diseases and restoring health by strengthening the body's natural barriers. The company focuses on microbiome-based therapeutic approaches.

1 investor

1 investor

Humanity Neurotech works on biophysics research aimed at improving human health.

1 investor

The Human Phenotype Project, powered by Pheno.AI, is a longitudinal multi-omic study that deeply profiles participants across multiple countries over 25 years to build research-ready health datasets. It provides these datasets and an end-to-end cohort-building solution to universities and research institutions working in healthcare, life sciences, and pharma.

1 investor

Humasis develops and manufactures in-vitro diagnostic medical devices, producing 163 product items through its central R&D lab focused on diagnostic source technologies. Founded in 2000, the South Korean company exports its diagnostic products to 74 countries.

1 investor

Humedics develops LiMAx, a breath analysis technology for rapid and precise measurement of liver function, enabling doctors to make tailored treatment decisions at the bedside. The company serves healthcare providers and hospitals in diagnostic medicine.

1 investor

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

HVR Cardio develops medical devices for cardiovascular applications, drawing on a management team with combined expertise in structural heart technologies and medical device commercialization.

1 investor

Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.

1 investor

HypaHub developed a data and AI platform for multiomic analysis to support biomarker discovery and drug development in biotechnology and life sciences. The platform has been acquired by GaudiBio and is now part of their offerings.

1 investor